KEY FEATURES
| Full Name | Cluster Of Differentiation 32 |
|---|---|
| Synonym | FcgRII; FCGR2A; FCG2; FCGR2A1; FCGR2; FCGR2B; FCGR2C; Receptor II For The Fc Region Of Immunoglobulin G; Fc Fragment Of IgG, Low Affinity IIa, Receptor; Low affinity immunoglobulin gamma Fc region rec |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 46.88-3000pg/mL |
| Sensitivity | 17.35pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CD32 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CD32. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CD32 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CD32, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CD32. You can calculate the concentration of Human CD32 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CD32 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 148.1 | 267.74 | 1038.27 | 139.38 | 262.15 | 1006.99 |
| Standard deviation | 8.2 | 10.76 | 31.87 | 8.27 | 10.64 | 51.66 |
| CV(%) | 5.54 | 4.02 | 3.07 | 5.93 | 4.06 | 5.13 |
RECOVERY
The recovery of Human CD32 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 96-109 | 102 |
| EDTA plasma (n=8) | 94-107 | 101 |
| Cell culture media (n=8) | 88-104 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CD32 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with FCGR2B ELISA Kits
| CRP ELISA Kit | publications with FCGR2B and CRP |
| LYN ELISA Kit | publications with FCGR2B and LYN |
| FCER1G ELISA Kit | publications with FCGR2B and FCER1G |
| PTPN11 ELISA Kit | publications with FCGR2B and PTPN11 |
| PTPN6 ELISA Kit | publications with FCGR2B and PTPN6 |
Pathways associated with FCGR2B ELISA Kit
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| B Cell Receptor Signaling Pathway | B Cell Receptor Signaling Pathway |
| BCR Signaling Pathway | BCR Signaling Pathway |
| Fc Gamma R-mediated Phagocytosis Pathway | Fc Gamma R-mediated Phagocytosis Pathway |
| Fc-epsilon Receptor I Signaling In Mast Cells Pathway | Fc-epsilon Receptor I Signaling In Mast Cells Pathway |
| Immune System Pathway | Immune System Pathway |
| Immunoregulatory Interactions Between A Lymphoid And A Non-Lymphoid Cell Pathway | Immunoregulatory Interactions Between A Lymphoid And A Non-Lymphoid Cell Pathway |
Diseases associated with FCGR2B ELISA Kit
| Autoimmune Diseases | publications with FCGR2B and Autoimmune Diseases |
| Lupus Erythematosus, Systemic | publications with FCGR2B and Lupus Erythematosus, Systemic |
| Inflammation | publications with FCGR2B and Inflammation |
| Kidney Diseases | publications with FCGR2B and Kidney Diseases |
| Necrosis | publications with FCGR2B and Necrosis |
| Nervous System Diseases | publications with FCGR2B and Nervous System Diseases |
| Lung Diseases | publications with FCGR2B and Lung Diseases |
| Skin Diseases | publications with FCGR2B and Skin Diseases |
| Anemia | publications with FCGR2B and Anemia |
| Liver Diseases | publications with FCGR2B and Liver Diseases |
Organs/Tissues associated with FCGR2B ELISA Kit
| Blood | publications with FCGR2B and Blood |
| Spleen | publications with FCGR2B and Spleen |
| Bone Marrow | publications with FCGR2B and Bone Marrow |
| Kidney | publications with FCGR2B and Kidney |
| Lymph Node | publications with FCGR2B and Lymph Node |
| Brain | publications with FCGR2B and Brain |
| Lung | publications with FCGR2B and Lung |
| Liver | publications with FCGR2B and Liver |
| Skin | publications with FCGR2B and Skin |
| Connective Tissue | publications with FCGR2B and Connective Tissue |